This site is intended for healthcare professionals

CDSCO in India grants Emergency Use approval for baricitinib + remdesivir to treat COVID 19.-Natco

Read time: 1 mins
Last updated:4th May 2021
Published:4th May 2021
Condition: Coronavirus/COVID-19 Infection
Type: drug
Register for free access to this exclusive healthcare learning resource

Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest